Yu Siying, Long Linna, Zhang Xiaorui, Qiu Yu, Huang Yabo, Huang Xueying, Li Xia, Xu Rong, Fan Chunmei, Huang He
Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, China.
Department of gynaecology, Xinjiang Cancer Hospital, Xinjiang Medical University, Urumqi, Xinjiang, China.
Heliyon. 2024 Aug 24;10(17):e36888. doi: 10.1016/j.heliyon.2024.e36888. eCollection 2024 Sep 15.
BACKGROUND: BET family proteins are important epigenetic and transcriptional regulators involved in the control of tumorigenesis and development and have become important targets for cancer therapy. However, there is no systematic bibliometric analysis in this field. A visual analysis of the research hotspots and trends of BET is helpful to understand the future development direction. METHOD: We used CiteSpace, VOSviewer, and Excel to visualize and analyze the trends regarding authors, journals, countries or regions, highly cited papers, and keywords in the field. RESULT: The results included a total of 946 publications. There are many more papers on BET proteins published since 2013. The papers are mainly from 44 countries, led by the U.S. and China. A total of 7381 authors were identified, among which Bradner, J.E. had the greatest number of articles and the greatest influence. Cancer Discovery was the journal with the most citations per article. Our analysis identified the most influential papers in the field, including highly cited papers and citation burst references. The most frequent keywords included 'expression', 'c-Myc', 'cancer', 'BRD4', 'BET inhibition', 'resistance', 'differentiation', and 'JQ1', which represent the focus of current and developing research fields. CONCLUSION: Research on BET is thriving. Collaboration and exchanges between countries and institutions must be strengthened in the future, and the mechanisms of BET-related pathways, the relationship between BET and various diseases, and the development of new BET inhibitors have become the major focus of current research and the trend of future research.
Heliyon. 2024-8-24
J Orthop Surg Res. 2020-10-8
Front Biosci (Landmark Ed). 2022-8-31
Eur J Med Chem. 2022-12-15
Medicine (Baltimore). 2024-1-19
Front Med (Lausanne). 2023-6-8
Front Cell Infect Microbiol. 2022
Front Immunol. 2023
Front Microbiol. 2023-1-9
J Exp Clin Cancer Res. 2022-11-11
Int J Environ Res Public Health. 2022-8-15
Neurosci Biobehav Rev. 2022-9
Clin Cancer Res. 2022-6-13
Front Oncol. 2022-3-21
J Control Release. 2022-5